NCT03037606

Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets

Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets on Intragastric and Intraesophageal Acidity

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 48 (actual)
• Sponsor: Neutec Ar-Ge San ve Tic A.Ş · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

It is planned to compare the efficacy and safety of rabeprazole 50 mg DDR (dual delayed release) capsules versus rabeprazole 20 mg enteric coated tablets administered once daily in patients with Gastroesophageal Reflux Disease (GERD).

Conditions

• Gastroesophageal Reflux Disease

Interventions

Type	Name	Description
DRUG	Rabelis DDR 50 mg Capsules	Rabelis DDR 50 mg Capsules once daily for seven days.
DRUG	Pariet 20 mg Enteric Coated Tablets	Pariet 20 mg Enteric Coated Tablets once daily for seven days.

Timeline

• Start date: 2017-08-01
• Primary completion: 2018-12-01
• Completion: 2018-12-11
• First posted: 2017-01-31
• Last updated: 2018-12-12

Locations

1 site across 1 country: Turkey (Türkiye)